Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	AP3_beta	AP3B1 AP3B2	3.07e-05	2	104	2	IPR026740
Domain	AP3B_C	AP3B1 AP3B2	3.07e-05	2	104	2	IPR029390
Domain	AP3B1_C	AP3B1 AP3B2	3.07e-05	2	104	2	PF14796
Domain	AP3B1_C	AP3B1 AP3B2	3.07e-05	2	104	2	SM01355
Domain	TIR	IL18R1 TLR3 IL1R1	2.07e-04	21	104	3	SM00255
Domain	TIR	IL18R1 TLR3 IL1R1	2.39e-04	22	104	3	PF01582
Domain	-	IL18R1 TLR3 IL1R1	2.74e-04	23	104	3	3.40.50.10140
Domain	AP_beta	AP3B1 AP3B2	3.04e-04	5	104	2	IPR026739
Domain	TIR	IL18R1 TLR3 IL1R1	3.12e-04	24	104	3	PS50104
Domain	TIR_dom	IL18R1 TLR3 IL1R1	3.53e-04	25	104	3	IPR000157
Domain	IL-1_rcpt_I/II-typ	IL18R1 IL1R1	4.54e-04	6	104	2	IPR004074
Pubmed	Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis.	CASP5 IL18R1 IL1R1	5.95e-07	6	109	3	31076358
Pubmed	Gasdermin D Restrains Type I Interferon Response to Cytosolic DNA by Disrupting Ionic Homeostasis.	CASP5 IL18R1 IL1R1	2.48e-06	9	109	3	30170814
Pubmed	IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice.	IL18R1 TLR3 IL1R1	3.54e-06	10	109	3	17992263
Pubmed	Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls.	ELP1 IL18R1 JAK2 TLR3 IL1R1 MUC7 ALOX5	3.87e-06	204	109	7	20503287
Pubmed	Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes.	ELP1 IL18R1 JAK2 TLR3 IL1R1 MUC7 ALOX5	4.00e-06	205	109	7	19258923
Pubmed	Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes.	ELP1 IL18R1 JAK2 TLR3 IL1R1 MUC7 ALOX5	4.26e-06	207	109	7	17703412
Pubmed	Identification of a key pathway required for the sterile inflammatory response triggered by dying cells.	IL18R1 TLR3 IL1R1	4.85e-06	11	109	3	17572686
Pubmed	Macrophage-derived IL-1α promotes sterile inflammation in a mouse model of acetaminophen hepatotoxicity.	CASP5 TLR3 IL1R1	8.37e-06	13	109	3	28504245
Pubmed	Hox2 Genes Are Required for Tonotopic Map Precision and Sound Discrimination in the Mouse Auditory Brainstem.	HOXA2 HOXB2	9.73e-06	2	109	2	28052248
Pubmed	T cell-intrinsic IL-1R signaling licenses effector cytokine production by memory CD4 T cells.	IL18R1 IL1R1	9.73e-06	2	109	2	30093707
Pubmed	Cutting Edge: IL-1R1 Mediates Host Resistance to Mycobacterium tuberculosis by Trans-Protection of Infected Cells.	PTPRC IL1R1	9.73e-06	2	109	2	30068597
Pubmed	Structure and function of Semaphorin-5A glycosaminoglycan interactions.	SEMA5A PLXNA2	9.73e-06	2	109	2	38548715
Pubmed	IL18 Receptor Signaling Inhibits Intratumoral CD8+ T-Cell Migration in a Murine Pancreatic Cancer Model.	IL18R1 IL1R1	9.73e-06	2	109	2	36766797
Pubmed	Downregulation of myosin II-B by siRNA alters the subcellular localization of the amyloid precursor protein and increases amyloid-beta deposition in N2a cells.	MYH10 APP	9.73e-06	2	109	2	17727819
Pubmed	Limiting RyR2 Open Time Prevents Alzheimer's Disease-Related Neuronal Hyperactivity and Memory Loss but Not β-Amyloid Accumulation.	APP RYR2	9.73e-06	2	109	2	32966798
Pubmed	Replication study of RAD54B and GREB1 polymorphisms and risk of PCOS in Han Chinese.	RAD54B GREB1	9.73e-06	2	109	2	23876972
Pubmed	Protein kinase C-dependent alpha-secretory processing of the amyloid precursor protein is mediated by phosphorylation of myosin II-B.	MYH10 APP	9.73e-06	2	109	2	19103644
Pubmed	JAK2 and PTPRC mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.	JAK2 PTPRC	9.73e-06	2	109	2	31760539
Pubmed	MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals.	IL18R1 TLR3 IL1R1	1.06e-05	14	109	3	16886064
Pubmed	DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88.	IL18R1 TLR3 IL1R1	2.36e-05	18	109	3	22541070
Pubmed	A piRNA pathway primed by individual transposons is linked to de novo DNA methylation in mice.	PIWIL2 DNMT3L	2.91e-05	3	109	2	18922463
Pubmed	IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model.	IL18R1 IL1R1	2.91e-05	3	109	2	36758176
Pubmed	The AP-3 complex required for endosomal synaptic vesicle biogenesis is associated with a casein kinase Ialpha-like isoform.	AP3B1 AP3B2	2.91e-05	3	109	2	10930456
Pubmed	Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera.	JAK2 PROC	2.91e-05	3	109	2	18768782
Pubmed	Amyloid β production is regulated by β2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor.	APP RYR2	2.91e-05	3	109	2	28476886
Pubmed	Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles.	APP ALOX5	2.91e-05	3	109	2	23951061
Pubmed	The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathways.	IL18R1 IL1R1	2.91e-05	3	109	2	24842757
Pubmed	Arthritogenic properties of double-stranded (viral) RNA.	TLR3 IL1R1	2.91e-05	3	109	2	15100310
Pubmed	Identification of Lmo1 as part of a Hox-dependent regulatory network for hindbrain patterning.	HOXA2 HOXB2	2.91e-05	3	109	2	17676642
Pubmed	Role for MyD88 signaling in murine gammaherpesvirus 68 latency.	TLR3 IL1R1	2.91e-05	3	109	2	18256152
Pubmed	Mumps Virus SH Protein Inhibits NF-κB Activation by Interacting with Tumor Necrosis Factor Receptor 1, Interleukin-1 Receptor 1, and Toll-Like Receptor 3 Complexes.	TLR3 IL1R1	2.91e-05	3	109	2	28659487
Pubmed	Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms.	JAK2 PTPRC	2.91e-05	3	109	2	35365653
Pubmed	Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression.	APP DNMT3L	2.91e-05	3	109	2	26911678
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	FLII APP HOXA2 HOXB2 LRPPRC NFRKB ZMYM1 SEC23A	3.81e-05	398	109	8	35016035
Pubmed	New genetic associations detected in a host response study to hepatitis B vaccine.	CASP5 APP IL18R1 TLR3 NFRKB HRH4 ADGRE5 SPARCL1 C8A IL1R1 EPHX4	5.76e-05	824	109	11	20237496
Pubmed	Inflammasome-derived cytokine IL18 suppresses amyloid-induced seizures in Alzheimer-prone mice.	APP IL18R1	5.82e-05	4	109	2	30127003
Pubmed	DNA methylation of retrotransposon genes is regulated by Piwi family members MILI and MIWI2 in murine fetal testes.	PIWIL2 DNMT3L	5.82e-05	4	109	2	18381894
Pubmed	Regulation of large dense-core vesicle volume and neurotransmitter content mediated by adaptor protein 3.	AP3B1 AP3B2	5.82e-05	4	109	2	16788073
Pubmed	CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling.	JAK2 PTPRC	5.82e-05	4	109	2	11201744
Pubmed	Role of the inflammasome-related cytokines Il-1 and Il-18 during infection with murine coronavirus.	IL18R1 IL1R1	5.82e-05	4	109	2	28895072
Pubmed	Intrinsic MyD88-Akt1-mTOR Signaling Coordinates Disparate Tc17 and Tc1 Responses during Vaccine Immunity against Fungal Pneumonia.	IL18R1 IL1R1	5.82e-05	4	109	2	26367276
Pubmed	Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ.	CASP5 IL18R1	5.82e-05	4	109	2	25367751
Pubmed	Increased Δ5- and Δ6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis.	FADS2 ALOX5	5.82e-05	4	109	2	21605700
Pubmed	IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells.	IL18R1 IL1R1	5.82e-05	4	109	2	10653850
Pubmed	Fe3+ Facilitates Endocytic Internalization of Extracellular Aβ1-42 and Enhances Aβ1-42-Induced Caspase-3/Caspase-4 Activation and Neuronal Cell Death.	CASP5 APP	5.82e-05	4	109	2	30402707
Pubmed	The Leukotriene B4 and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita.	PTPRC ALOX5	5.82e-05	4	109	2	28108297
Pubmed	Crucial role for T cell-intrinsic IL-18R-MyD88 signaling in cognate immune response to intracellular parasite infection.	IL18R1 IL1R1	5.82e-05	4	109	2	28895840
Pubmed	IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection.	IL18R1 IL1R1	5.82e-05	4	109	2	17617611
Pubmed	Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells.	IL18R1 IL1R1	5.82e-05	4	109	2	24439266
Pubmed	Flightless-I regulates proinflammatory caspases by selectively modulating intracellular localization and caspase activity.	FLII CASP5	5.82e-05	4	109	2	18411310
Pubmed	Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation.	AP3B1 LRPPRC PI4KA SNRNP200	7.97e-05	72	109	4	36376293
Pubmed	Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.	LGMN APP	9.67e-05	5	109	2	28826672
Pubmed	Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles.	CASP5 IL1R1	9.67e-05	5	109	2	36652908
Pubmed	The DNA methyltransferase DNMT3C protects male germ cells from transposon activity.	PIWIL2 DNMT3L	9.67e-05	5	109	2	27856912
Pubmed	Semaphorin 5A inhibits synaptogenesis in early postnatal- and adult-born hippocampal dentate granule cells.	SEMA5A PLXNA2	9.67e-05	5	109	2	25313870
Pubmed	Cytotoxic CD4+ T cells driven by T-cell intrinsic IL-18R/MyD88 signaling predominantly infiltrate Trypanosoma cruzi-infected hearts.	IL18R1 IL1R1	9.67e-05	5	109	2	35670567
Pubmed	Adaptor protein-3 produces synaptic vesicles that release phasic dopamine.	AP3B1 AP3B2	9.67e-05	5	109	2	37812725
Pubmed	Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging.	CASP5 IL1R1	9.67e-05	5	109	2	24093676
Pubmed	Association analysis between schizophrenia and the AP-3 complex genes.	AP3B1 AP3B2	9.67e-05	5	109	2	19481122
Pubmed	Nlrp3-dependent IL-1β inhibits CD103+ dendritic cell differentiation in the gut.	IL18R1 IL1R1	9.67e-05	5	109	2	29515025
Pubmed	Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q.	IL18R1 IL1R1	9.67e-05	5	109	2	10191101
Pubmed	Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice.	IL18R1 TLR3	9.67e-05	5	109	2	18654661
Pubmed	Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome.	CASP5 IL18R1	9.67e-05	5	109	2	37993714
Pubmed	Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.	TLR3 IL1R1	9.67e-05	5	109	2	20956347
Pubmed	Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.	ZPBP IL18R1 JAK2 FADS2 UBAC2 IL1R1 TRIB1	1.06e-04	342	109	7	23128233
Pubmed	Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta.	APP TF	1.45e-04	6	109	2	18813964
Pubmed	Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses.	TLR3 IL1R1	1.45e-04	6	109	2	18295350
Pubmed	PlexinA2 Forward Signaling through Rap1 GTPases Regulates Dentate Gyrus Development and Schizophrenia-like Behaviors.	SEMA5A PLXNA2	1.45e-04	6	109	2	29320740
Pubmed	Genetic analysis of the neuronal and ubiquitous AP-3 adaptor complexes reveals divergent functions in brain.	AP3B1 AP3B2	1.45e-04	6	109	2	15537701
Pubmed	A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene.	HOXA2 HOXB2	1.45e-04	6	109	2	7903601
Pubmed	Protective effect of IL-18 on kainate- and IL-1 beta-induced cerebellar ataxia in mice.	IL18R1 IL1R1	1.45e-04	6	109	2	18250441
Pubmed	DNA hypomethylation promotes the expression of CASPASE-4 which exacerbates inflammation and amyloid-β deposition in Alzheimer's disease.	CASP5 APP	1.45e-04	6	109	2	38326859
Pubmed	Contrasting roles of the IL-1 and IL-18 receptors in MyD88-dependent contact hypersensitivity.	IL18R1 IL1R1	1.45e-04	6	109	2	19657352
Pubmed	Macrophage priming is dispensable for NLRP3 inflammasome activation and restriction of Leishmania amazonensis replication.	CASP5 IL1R1	1.45e-04	6	109	2	31063608
Pubmed	Uric acid-driven Th17 differentiation requires inflammasome-derived IL-1 and IL-18.	IL18R1 IL1R1	1.45e-04	6	109	2	22058415
Pubmed	MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.	IL18R1 IL1R1	1.45e-04	6	109	2	19079579
Pubmed	Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity.	CASP5 PHAF1 FRY NFRKB IL1R1 PRIMPOL	1.87e-04	263	109	6	19773279
Pubmed	Mice with targeted disruption of Hoxb-1 fail to form the motor nucleus of the VIIth nerve.	HOXA2 HOXB2	2.02e-04	7	109	2	8898234
Pubmed	Nonredundant roles of TIRAP and MyD88 in airway response to endotoxin, independent of TRIF, IL-1 and IL-18 pathways.	IL18R1 IL1R1	2.02e-04	7	109	2	16983331
Pubmed	An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode.	TLR3 IL1R1	2.02e-04	7	109	2	25964372
Pubmed	Characterization of the adaptor-related protein complex, AP-3.	AP3B1 AP3B2	2.02e-04	7	109	2	9151686
Pubmed	The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages.	CASP5 TLR3	2.02e-04	7	109	2	29520027
Pubmed	Bacterial Endotoxin Activates the Coagulation Cascade through Gasdermin D-Dependent Phosphatidylserine Exposure.	CASP5 IL1R1	2.02e-04	7	109	2	31836429
Pubmed	Combined factor VII/protein C deficiency results in intrauterine coagulopathy in mice.	PTPRC PROC	2.02e-04	7	109	2	10749569
Pubmed	MyD88 Shapes Vaccine Immunity by Extrinsically Regulating Survival of CD4+ T Cells during the Contraction Phase.	TLR3 IL1R1	2.02e-04	7	109	2	27542117
Pubmed	Caspase-1-independent interleukin-1β is required for clearance of Bordetella pertussis infections and whole-cell vaccine-mediated immunity.	CASP5 IL1R1	2.02e-04	7	109	2	25198773
Pubmed	Interdependence between Interleukin-1 and Tumor Necrosis Factor Regulates TNF-Dependent Control of Mycobacterium tuberculosis Infection.	CASP5 IL1R1	2.02e-04	7	109	2	26682985
Pubmed	Effects of chronically increased VEGF-A on the aging heart.	CASP5 IL1R1	2.02e-04	7	109	2	29146733
Pubmed	Hoxa1 and Krox-20 synergize to control the development of rhombomere 3.	HOXA2 HOXB2	2.02e-04	7	109	2	9806922
Pubmed	Genome-wide association study to identify genetic determinants of severe asthma.	IL18R1 IL1R1	2.02e-04	7	109	2	22561531
Pubmed	Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.	IL18R1 IL1R1	2.02e-04	7	109	2	24084736
Pubmed	A novel sorting nexin modulates endocytic trafficking and alpha-secretase cleavage of the amyloid precursor protein.	APP TF	2.02e-04	7	109	2	18353773
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	GLB1L3 BCAS3 SEMA5A ADGRV1 GTDC1 RYR2 BTBD3 GREB1 SPAG16 TRIB1	2.48e-04	814	109	10	23251661
Pubmed	Loss of Bladder Epithelium Induced by Cytolytic Mast Cell Granules.	CASP5 IL1R1	2.69e-04	8	109	2	27939674
Pubmed	Uncoupling between inflammatory and fibrotic responses to silica: evidence from MyD88 knockout mice.	TLR3 IL1R1	2.69e-04	8	109	2	25050810
Pubmed	Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1.	CASP5 IL1R1	2.69e-04	8	109	2	26203636
Pubmed	Association of the AP-3 adaptor complex with clathrin.	AP3B1 AP3B2	2.69e-04	8	109	2	9545220
Pubmed	Cytokine regulation of lung Th17 response to airway immunization using LPS adjuvant.	TLR3 IL1R1	2.69e-04	8	109	2	27328989
Pubmed	MyD88 Adaptor-Dependent Microbial Sensing by Regulatory T Cells Promotes Mucosal Tolerance and Enforces Commensalism.	IL18R1 IL1R1	2.69e-04	8	109	2	26231118
Pubmed	Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease.	IL18R1 JAK2	2.69e-04	8	109	2	19249008
GeneFamily	Olfactory receptors, family 12	OR12D3 OR12D1	4.55e-05	3	71	2	160
Coexpression	GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	YPEL3 RIPOR2 LIMD1 AHCYL2 PHAF1 NFRKB UBAC2	1.97e-05	200	108	7	M6253
Coexpression	GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN	YPEL3 RNF144A PIWIL2 IL18R1 JAK2 PTPRC UBAC2	1.97e-05	200	108	7	M5271
Coexpression	GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	RIN3 RNF144A IL18R1 JAK2 HRH4 TRIB1 ALOX5	1.97e-05	200	108	7	M5416
Coexpression	GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN	FLII MYH10 HOXA2 PI4KA TLR3 SPARCL1 C8A	1.97e-05	200	108	7	M6187
Coexpression	PARENT_MTOR_SIGNALING_UP	FLII BCAS3 PIWIL2 AP3B1 PAPSS1 TF JAK2 PI4KA CTDP1 DNAAF1 IL1R1	2.29e-05	567	108	11	M16909
Coexpression	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	SFRP1 OMD TF SPARCL1	3.89e-05	46	108	4	M14142
Coexpression	COLLIS_PRKDC_SUBSTRATES	DCLRE1C CTDP1 SNRNP200	4.44e-05	17	108	3	M4495
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	LGMN MYH10 SKIDA1 TSN PAPSS1 SULF1 PI4KA SPARCL1 IL1R1	5.23e-05	411	108	9	M1351
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	LGMN MYH10 SKIDA1 TSN PAPSS1 SULF1 PI4KA SPARCL1 IL1R1	5.74e-05	416	108	9	MM1002
Coexpression	GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN	SFRP1 ZPBP RNF144A VPS8 SEMA5A TLR3	5.78e-05	162	108	6	M6084
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 RYR2 SULF1 WDR17 DNAH9 UNC80 PDZRN4	1.48e-07	160	110	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 RYR2 SULF1 WDR17 DNAH9 UNC80 PDZRN4	1.48e-07	160	110	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	MYH10 SEMA5A RYR2 FRY SULF1 SPARCL1 PDZRN4	4.25e-07	187	110	7	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 RIPOR2 CASP5 PTPRC ADGRE5 KYNU ALOX5	5.63e-07	195	110	7	10ce1b6961f10372d1f65388cbf3626a5fcd6840
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 RIPOR2 PTPRC ADGRE5 KYNU ALOX5	4.56e-06	173	110	6	0a0127bcb1d7b2b6125faef576dd843055095528
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LGMN ADGRV1 RYR2 DNAH9 UNC80 PDZRN4	4.87e-06	175	110	6	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C11orf97 SPAG16 DNAAF1 EPHX4 DNAH9 PROC	7.12e-06	187	110	6	04dba2ed09ee4180830bdf0191921696697ea234
ToppCell	facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C11orf97 SPAG16 DNAAF1 EPHX4 DNAH9 PROC	7.12e-06	187	110	6	805dafe22f835ece4dd091d8030d0a63b52a48dd
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 RIPOR2 PTPRC ADGRE5 KYNU ALOX5	7.34e-06	188	110	6	4e27ada1bda88811b73376c8a6136cbfc83bfdb9
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RIN3 IL18R1 PTPRC ADGRE5 KYNU ALOX5	7.80e-06	190	110	6	ad297172a74a80ed5c10f921e15efd1da0fd2d6b
ToppCell	COVID-19-kidney-Myeloid\|kidney / Disease (COVID-19 only), tissue and cell type	RIPOR2 IL18R1 PTPRC ADGRE5 IL1R1 ALOX5	8.28e-06	192	110	6	441cd1ec171f643b28e1f6f9c04def629cc7391b
ToppCell	COVID-19-kidney-Myeloid\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RIPOR2 IL18R1 PTPRC ADGRE5 IL1R1 ALOX5	8.28e-06	192	110	6	0b9d22a222f1201e375f8e55cace9ef939febae4
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 RYR2 JAK2 FRY SPARCL1 PDZRN4	8.78e-06	194	110	6	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 RYR2 JAK2 FRY SPARCL1 PDZRN4	8.78e-06	194	110	6	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 RIPOR2 PTPRC ADGRE5 KYNU ALOX5	9.04e-06	195	110	6	1d58585557bf8e9ce4d514e128d3a902b526331d
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	DEPTOR PAPSS1 IL18R1 FRY HRH4 ALOX5	9.04e-06	195	110	6	fbedb9978ded857fd35c2a8664f7579f42edaa36
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SFRP1 SEMA5A RYR2 SULF1 FADS2 SPARCL1	9.31e-06	196	110	6	525d6c8a277364e624e7cc586275f8a891436b57
ToppCell	COPD-Stromal-Fibroblast\|Stromal / Disease state, Lineage and Cell class	SFRP1 OMD CYP4Z2P SULF1 GREB1 PDZRN4	9.31e-06	196	110	6	4930eeb303d174c28fd91021723e26fdf1af9170
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH10 RYR2 FRY SULF1 SPARCL1 PDZRN4	9.58e-06	197	110	6	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SFRP1 OMD SULF1 SPARCL1 GREB1 PDZRN4	1.01e-05	199	110	6	f835e7ffe976843b0edbf695762d463da85793f3
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SFRP1 OMD SULF1 SPARCL1 GREB1 PDZRN4	1.01e-05	199	110	6	993fa050a095017135a6e723c77cd38b9d782e58
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH10 RYR2 FRY SULF1 SPARCL1 PDZRN4	1.04e-05	200	110	6	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Nxph2_Sla\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SEMA5A TEKT5 LLGL2 TRIB1 PDZRN4	2.07e-05	134	110	5	6d97fa07f55ae20c17b9d5262e893957cccc6dba
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RIPOR2 OMD SULF1 UBAC2 SPARCL1	3.56e-05	150	110	5	909ccab92855f5f049dc29593aadab1ea973297b
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RIN3 IL18R1 PTPRC RAD54B ADGRE5	3.67e-05	151	110	5	535872e231ac0ee7b4fc4d02a260752cbbf50a2b
ToppCell	facs-Trachea-nan-24m-Myeloid-granulocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIN3 NPHS2 PTPRC HRH4 ALOX5	3.67e-05	151	110	5	26fd55efb647c41436416d45952ee97b050e632c
ToppCell	facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHCYL2 LLGL2 TLR3 FADS2 KYNU	4.42e-05	157	110	5	5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446
ToppCell	facs-Marrow-KLS-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHCYL2 LLGL2 TLR3 FADS2 KYNU	4.42e-05	157	110	5	ad9c9b7dfeee3ae46e7e593c51a0407df12195b4
ToppCell	facs-Trachea-24m-Hematologic-myeloid-granulocyte\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RIN3 NPHS2 PTPRC HRH4 ALOX5	4.42e-05	157	110	5	188d2f85babcd4eefe20e7a392d851b2e1185bab
ToppCell	facs-Lung-nan-3m-Lymphocytic-Natural_Killer\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPOR2 ZPBP IL18R1 PTPRC HRH4	4.98e-05	161	110	5	ae1cee34361dde9964581cca99a29578c3b3bd99
ToppCell	facs-Lung-nan-3m-Lymphocytic-NK_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPOR2 ZPBP IL18R1 PTPRC HRH4	4.98e-05	161	110	5	33de3e8b3238fcfc66dfbf89a913a07d464d6c35
ToppCell	droplet-Fat-Gat-18m-Myeloid\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPOR2 ELP1 PTPRC TRIB1 ALOX5	5.60e-05	165	110	5	c3ca2b35299294a5e3d1881fd11617e3ab720692
ToppCell	droplet-Fat-Gat-18m-Myeloid-myeloid_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPOR2 ELP1 PTPRC TRIB1 ALOX5	5.60e-05	165	110	5	af32eae9324ef053f4f76e2144fb84c6e264c482
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL18R1 JAK2 HRH4 ALOX5 UNC80	5.76e-05	166	110	5	c22b0f3bf990d94b615a3aacee5de548da2db628
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL18R1 JAK2 HRH4 ALOX5 UNC80	5.76e-05	166	110	5	0975fc165bcc7e85f053d9d0244fffe407c23571
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 IL18R1 PTPRC ADGRE5 ALOX5	6.27e-05	169	110	5	2e15a9317da4017757d184f7cc91bd66b072ac51
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Basophil\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RIPOR2 IL18R1 JAK2 HRH4 ALOX5	6.45e-05	170	110	5	bca78719c17355772ad6c53ee75e459faf1d089f
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RIPOR2 IL18R1 JAK2 HRH4 ALOX5	6.45e-05	170	110	5	40d863554ec98ae43f76511c1112859688846613
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	RIPOR2 PTPRC CTDP1 TRIB1 ALOX5	6.63e-05	171	110	5	2b7c5a557c4bc5c573211c4d618bdd6766a24916
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	RIPOR2 PTPRC CTDP1 TRIB1 ALOX5	6.63e-05	171	110	5	dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f
ToppCell	droplet-Marrow-nan-3m-Hematologic-proerythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPOR2 ELP1 PTPRC TRIB1 ALOX5	6.82e-05	172	110	5	cfcfa7eeff1805bedf10a3c07826459914c3e872
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 IL18R1 PTPRC ADGRE5 ALOX5	7.01e-05	173	110	5	9eaec30f9a3655b53ece1b66848201a7f85bbdf5
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNF183 ADGRV1 BTBD3 FNDC11 AP3B2	7.20e-05	174	110	5	a62531ebf16b32b249168dca11b870f63a8aa81c
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PAPSS1 FRY FNDC11 HRH4 ALOX5	7.40e-05	175	110	5	ba1befc4e5f0167452f9ceace39377d16136dfa9
ToppCell	Control-Lymphoid-pDC\|Control / Condition, Lineage and Cell class	LGMN APP IL18R1 FADS2 PROC	7.60e-05	176	110	5	5de16ff65476bde8b23322a44e11412e14f1bafe
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_early_2\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	PTPRC SULF1 SPARCL1 C11orf97 DNAAF1	7.60e-05	176	110	5	8e0ac3ad5e47614b4befabd674a40e3eaae553f3
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RIPOR2 IL18R1 PTPRC ADGRE5 EPHX4	8.02e-05	178	110	5	a96941fef62c2f4533c557ef825ae3265f8f52db
ToppCell	droplet-Bladder-nan-24m-Epithelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFRP1 HRH4 SPARCL1 SPAG16 UNC80	8.23e-05	179	110	5	dfd9d29281510d32f1a2e8336d2e58ef496cfd1d
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LRRC63 RIN3 SPARCL1 PLXNA2 DNMT3L	8.45e-05	180	110	5	455d1e3ccf2ab609954f3b870e8f514ddca735f4
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	RNF144A OMD SULF1 AP3B2 FADS2	8.45e-05	180	110	5	886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	MYH10 RYR2 SULF1 SPARCL1 PDZRN4	8.45e-05	180	110	5	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 RIPOR2 PTPRC ADGRE5 ALOX5	8.67e-05	181	110	5	8657d35cd3dff6c89d0fde67d7e7e81e1d6c8884
ToppCell	facs-GAT-Fat-3m-Epithelial-epithelial_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TEKT5 C11orf97 SPAG16 DNAH9 PROC	8.67e-05	181	110	5	e97cbaafb93fdbee8e3cf4a06e6bcf121d941403
ToppCell	facs-GAT-Fat-3m-Epithelial\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TEKT5 C11orf97 SPAG16 DNAH9 PROC	8.67e-05	181	110	5	11cb84528f7ca084f0a92eda4f2e18e63a428fe9
ToppCell	facs-GAT-Fat-3m-Epithelial-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TEKT5 C11orf97 SPAG16 DNAH9 PROC	8.67e-05	181	110	5	5ffeca29e4d31a20c110d27af128ed024a79ad56
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	RIPOR2 PTPRC CTDP1 TRIB1 ALOX5	8.90e-05	182	110	5	dc32f8f6a3b13918eb8e93c018f5823d86344080
ToppCell	severe-Myeloid-Neutrophils_1\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	YPEL3 RIPOR2 FRY PTPRC IL1R1	9.13e-05	183	110	5	60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	MYH10 FRY ADGRE5 SPARCL1 PDZRN4	9.13e-05	183	110	5	818fd886e0188091310825f9145fa53328f2c979
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA5A FRY NPHS2 SULF1 DNAH9	9.13e-05	183	110	5	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA5A FRY NPHS2 SULF1 DNAH9	9.13e-05	183	110	5	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	MYH10 FRY ADGRE5 SPARCL1 PDZRN4	9.13e-05	183	110	5	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AP3B1 IL18R1 JAK2 TDRD10 PLXNA2	9.37e-05	184	110	5	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	NS-moderate-d_07-13-Myeloid-Neutrophil\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	YPEL3 RIPOR2 CASP5 PTPRC TRIB1	9.37e-05	184	110	5	4c7d05f1a4556b13cedbaaf88d67ac32d09b109b
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ANKRD31 DEPTOR FADS2 ALOX5 PROC	9.37e-05	184	110	5	1c56378b3888c46258d446b47de4d6282fe74b0d
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ANKRD31 DEPTOR FADS2 ALOX5 PROC	9.37e-05	184	110	5	a45980306c4e697a2703bed72a7b48fb23d942f4
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MYH10 LIMD1 DNAJC27 PHAF1 KYNU	9.86e-05	186	110	5	77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA5A RYR2 SULF1 WDR17 PDZRN4	9.86e-05	186	110	5	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MYH10 LIMD1 DNAJC27 PHAF1 KYNU	9.86e-05	186	110	5	13bc41c60fd628af31899a5e8b480e06cc4781be
ToppCell	tumor_Lung-Epithelial_cells-tS3\|Epithelial_cells / Location, Cell class and cell subclass	RIPOR2 SFRP1 C11orf97 DNAAF1 DNAH9	1.01e-04	187	110	5	3cea677279e71fdb9879530dea10a5e6393beacd
ToppCell	facs-Pancreas-Exocrine-24m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFRP1 HOXA2 SULF1 HRH4 SPARCL1	1.01e-04	187	110	5	0f90bce2087aecfdbb377e6f46c6e468efbb6e28
ToppCell	facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFRP1 HOXA2 SULF1 HRH4 SPARCL1	1.01e-04	187	110	5	76c957b2976d38adb45e07bcf96c689442e1fc20
ToppCell	facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFRP1 HOXA2 SULF1 HRH4 SPARCL1	1.01e-04	187	110	5	90a1078b0303799fba5d2ca4fa12076fd75b78b1
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	MYH10 RYR2 FRY ADGRE5 PDZRN4	1.04e-04	188	110	5	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	E12.5-Mesenchymal\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYH10 SFRP1 HOXA2 HOXB2 SPARCL1	1.04e-04	188	110	5	9778dadc2bd7ded3a723e717d1c8cd3160e99c6c
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	RIN3 RIPOR2 PTPRC KYNU ALOX5	1.06e-04	189	110	5	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RYR2 JAK2 FRY SPARCL1 PDZRN4	1.06e-04	189	110	5	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	MYH10 FRY SULF1 ADGRE5 PDZRN4	1.06e-04	189	110	5	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RYR2 JAK2 FRY SPARCL1 PDZRN4	1.06e-04	189	110	5	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	COVID-19-Heart-Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LGMN RIN3 PTPRC KYNU ALOX5	1.06e-04	189	110	5	2586f4088721c5debec86c2b211b739fd33713eb
ToppCell	(1)_T_cells-(1)_T_CD4_reg\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	LGMN BCAS3 HOXB2 IL1R1 TRIB1	1.09e-04	190	110	5	ff42af092173c2d4472bb9a02f5a334c272e05a0
ToppCell	Control-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	OMD SULF1 SPARCL1 IL1R1 PDZRN4	1.09e-04	190	110	5	4e30155203b4a8c5e496fcbe9348b67b98ebc625
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	RIPOR2 PTPRC DNAAF1 KYNU ALOX5	1.14e-04	192	110	5	d44f46352bac414b45cc749f7cbdc3a159bd7ae8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RYR2 JAK2 FRY SPARCL1 PDZRN4	1.14e-04	192	110	5	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RYR2 JAK2 FRY SPARCL1 PDZRN4	1.14e-04	192	110	5	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	CYP4Z2P C11orf97 SPAG16 DNAAF1 DNAH9	1.14e-04	192	110	5	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-oRG-34\|World / Primary Cells by Cluster	SFRP1 SEMA5A ADGRV1 SPARCL1 SPAG16	1.17e-04	193	110	5	d55f792eb3db10452347681131e07e041348fd89
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ADGRV1 SPARCL1 DNAAF1 DNAH9 PLXNA2	1.17e-04	193	110	5	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	control-Myeloid-Neutrophils_3\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	YPEL3 RIPOR2 IL18R1 TRIB1 ALOX5	1.17e-04	193	110	5	56daf3c59a124dd068af5409113913d9ee81a454
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RIPOR2 PTPRC DNAAF1 KYNU ALOX5	1.17e-04	193	110	5	b044fca95f519ff2ceb378afe40a95911931a29e
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	MYH10 BCAS3 RYR2 SPARCL1 PLXNA2	1.17e-04	193	110	5	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	Non-neuronal-Non-dividing\|World / Primary Cells by Cluster	SFRP1 SEMA5A ADGRV1 SPARCL1 SPAG16	1.20e-04	194	110	5	0add09d97192b34bd506209ab5f1a77182f498fc
ToppCell	IPF-Stromal-Fibroblast\|Stromal / Disease state, Lineage and Cell class	SFRP1 OMD CYP4Z2P GREB1 PDZRN4	1.20e-04	194	110	5	da3e1d39575969a069ef43e552afe94b2f441d0b
ToppCell	IPF-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	IL18R1 SULF1 SPARCL1 IL1R1 PDZRN4	1.20e-04	194	110	5	e8a9005963704286bcc50785bda8d7d63ec001b1
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)-SMG_serous_(bronchial)_L.0.6.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DEPTOR TF EPHX4 MUC7 UNC80	1.20e-04	194	110	5	a8238f312a973cadf6eb29c1e02ba898c0a20412
ToppCell	control-Myeloid-Neutrophils_3\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	YPEL3 RIPOR2 IL18R1 TRIB1 ALOX5	1.20e-04	194	110	5	2218e6677dc6781a6e4ef3a315f2298cc2cd9df2
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	SEMA5A RYR2 FRY SPARCL1 PDZRN4	1.20e-04	194	110	5	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	YPEL3 ADGRV1 SULF1 DNAH9 UNC80	1.23e-04	195	110	5	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SFRP1 OMD SULF1 SPARCL1 GREB1	1.23e-04	195	110	5	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RIN3 IL18R1 PTPRC KYNU ALOX5	1.23e-04	195	110	5	9c6bed8414633813e1655bbeaab682fb296958a9
ToppCell	IPF-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	SFRP1 OMD SULF1 SPARCL1 GREB1	1.23e-04	195	110	5	9c32756edb54f0c211185d9a98073fe01fd1526a
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	FLII JADE3 TSN AHCYL2 GTDC1 CTDP1 NFRKB FADS2 SEC23A	3.88e-07	195	108	9	1144_DN
Disease	asthma (is_implicated_in)	ELP1 IL18R1 TLR3 MUC7 ALOX5 PROC	2.52e-05	157	108	6	DOID:2841 (is_implicated_in)
Disease	lysophosphatidylethanolamine 20:4 measurement	SFRP1 FADS2 SEC23A	1.63e-04	29	108	3	EFO_0010370
Disease	Crohn's disease	IL18R1 JAK2 PTPRC SULF1 FADS2 UBAC2 IL1R1 TRIB1	2.23e-04	441	108	8	EFO_0000384
Disease	inflammatory bowel disease	IL18R1 JAK2 GLMN PTPRC FADS2 UBAC2 TRIB1 PLXNA2	2.52e-04	449	108	8	EFO_0003767
Disease	basophil count, eosinophil count	RIN3 IL18R1 JAK2 PTPRC FADS2 UBAC2	2.67e-04	241	108	6	EFO_0004842, EFO_0005090
Disease	Inherited susceptibility to asthma	MUC7 ALOX5	3.66e-04	8	108	2	cv:C1869116
Disease	ASTHMA, SUSCEPTIBILITY TO	MUC7 ALOX5	3.66e-04	8	108	2	600807
Disease	Inhalant adrenergic use measurement	IL18R1 PTPRC FADS2 UBAC2	4.35e-04	96	108	4	EFO_0009941
Disease	interleukin 1 receptor-like 1 measurement	IL18R1 IL1R1	7.14e-04	11	108	2	EFO_0008168
Disease	serum ST2 measurement	IL18R1 IL1R1	7.14e-04	11	108	2	EFO_0005416
Disease	Situs Inversus	ANKS6 DNAH9	7.14e-04	11	108	2	C0037221
Disease	ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis	IL18R1 JAK2 GLMN UBAC2 IL1R1 TRIB1	7.74e-04	295	108	6	EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268
Disease	omega-6:omega-3 polyunsaturated fatty acid ratio	FADS2 UBAC2 TRIB1	8.25e-04	50	108	3	EFO_0010732
Disease	Thromboembolism	JAK2 PROC	8.55e-04	12	108	2	C0040038
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	ANKRD31 FADS2 TRIB1	8.74e-04	51	108	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	cholesterol to total lipids in small VLDL percentage	ANKRD31 FADS2 TRIB1	8.74e-04	51	108	3	EFO_0022242
Disease	cholesterol to total lipids in large HDL percentage	ETFDH FADS2 TRIB1	1.09e-03	55	108	3	EFO_0022234
Disease	free cholesterol to total lipids in very large HDL percentage	ETFDH FADS2 TRIB1	1.09e-03	55	108	3	EFO_0022288
Disease	severe combined immunodeficiency (is_implicated_in)	PTPRC DCLRE1C	1.17e-03	14	108	2	DOID:627 (is_implicated_in)
Disease	triglycerides to total lipids in small VLDL percentage	ANKRD31 FADS2 TRIB1	1.27e-03	58	108	3	EFO_0022338
Disease	cholesteryl esters to total lipids in large HDL percentage	ETFDH FADS2 TRIB1	1.34e-03	59	108	3	EFO_0022248
Disease	interleukin 18 receptor 1 measurement	IL18R1 IL1R1	1.35e-03	15	108	2	EFO_0008178
Disease	thrombosis (is_implicated_in)	JAK2 PROC	1.35e-03	15	108	2	DOID:0060903 (is_implicated_in)
Disease	triglycerides to total lipids in large HDL percentage	ETFDH FADS2 TRIB1	1.40e-03	60	108	3	EFO_0022330
Disease	free cholesterol in very large VLDL measurement	ANKRD31 FADS2 TRIB1	1.47e-03	61	108	3	EFO_0022274
Disease	monocyte percentage of leukocytes	ETFDH JAK2 GLMN OR52I2 PTPRC PI4KA CTDP1 FADS2 TRIB1	1.48e-03	731	108	9	EFO_0007989
Disease	serum albumin measurement	RIN3 SKIDA1 ETFDH ADGRV1 TF FRY FADS2 TRIB1	1.52e-03	592	108	8	EFO_0004535
Disease	vitamin C measurement	BCAS3 FADS2	1.54e-03	16	108	2	EFO_0600003
Disease	eosinophil percentage of leukocytes	RIN3 ZPBP IL18R1 JAK2 PTPRC FADS2 UBAC2 TRIB1 DNMT3L	1.70e-03	746	108	9	EFO_0007991
Disease	eosinophil percentage of granulocytes	IL18R1 JAK2 PTPRC UBAC2 DNMT3L	1.73e-03	234	108	5	EFO_0007996
Disease	total lipids in very large HDL measurement	ETFDH FADS2 TRIB1	1.85e-03	66	108	3	EFO_0022312
Disease	phospholipids in very large HDL measurement	ETFDH FADS2 TRIB1	1.85e-03	66	108	3	EFO_0022298
Disease	phosphatidylcholine 36:4 measurement	RIPOR2 FADS2	1.95e-03	18	108	2	EFO_0010382
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	ANKRD31 ETFDH FADS2 TRIB1	1.97e-03	144	108	4	EFO_0004611, EFO_0020943
Disease	free cholesterol in large VLDL measurement	ANKRD31 FADS2 TRIB1	2.01e-03	68	108	3	EFO_0022265
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	ANKRD31 FADS2 TRIB1	2.10e-03	69	108	3	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	cholesterol in very large HDL measurement	ETFDH FADS2 TRIB1	2.10e-03	69	108	3	EFO_0022229
Disease	portal hypertension (implicated_via_orthology)	JAK2 ALOX5	2.18e-03	19	108	2	DOID:10762 (implicated_via_orthology)
Disease	sodium-coupled monocarboxylate transporter 1 measurement	FADS2 TRIB1	2.18e-03	19	108	2	EFO_0802076
Disease	Omenn Syndrome	PTPRC DCLRE1C	2.18e-03	19	108	2	C2700553
Disease	iron biomarker measurement, transferrin measurement	TF FADS2	2.42e-03	20	108	2	EFO_0004461, EFO_0006341
Disease	Severe Combined Immunodeficiency	PTPRC DCLRE1C	2.42e-03	20	108	2	C0085110
Disease	nucleotide measurement	GTDC1 SULF1 PLXNA2	2.46e-03	73	108	3	EFO_0010513
Disease	total lipids in large HDL	ETFDH FADS2 TRIB1	2.56e-03	74	108	3	EFO_0022189
Disease	free cholesterol to total lipids in small VLDL percentage	ANKRD31 FADS2 TRIB1	2.66e-03	75	108	3	EFO_0022287
Disease	ST2 protein measurement	IL18R1 IL1R1	2.66e-03	21	108	2	EFO_0010599
Disease	Deep Vein Thrombosis	JAK2 PROC	2.66e-03	21	108	2	C0149871
Disease	Venous Thrombosis	JAK2 PROC	2.66e-03	21	108	2	C0042487
Disease	saturated fatty acids to total fatty acids percentage	FADS2 TRIB1	2.66e-03	21	108	2	EFO_0022305
Disease	in situ carcinoma (is_marker_for)	SFRP1 ALOX5	2.66e-03	21	108	2	DOID:8719 (is_marker_for)
Disease	asthma, response to diisocyanate	RIPOR2 AP3B1 CTDP1 GREB1 PDZRN4	2.77e-03	261	108	5	EFO_0006995, MONDO_0004979
Disease	Lung diseases	AP3B1 ADGRE5 DNAAF1	2.97e-03	78	108	3	C0024115
Disease	citrate measurement	RNF144A FADS2 TRIB1	3.08e-03	79	108	3	EFO_0010114
Disease	free cholesterol in large HDL measurement	ETFDH FADS2 TRIB1	3.08e-03	79	108	3	EFO_0022157
Disease	eosinophil count	RIN3 ZPBP DNAJC27 IL18R1 JAK2 GLMN PTPRC FADS2 UBAC2 IL1R1 SNRNP200 TRIB1 DNMT3L	3.09e-03	1488	108	13	EFO_0004842
Disease	cholesterol in large HDL measurement	ETFDH FADS2 TRIB1	3.19e-03	80	108	3	EFO_0021900
Disease	nephrotic syndrome (implicated_via_orthology)	NPHS2 ALOX5	3.48e-03	24	108	2	DOID:1184 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
FNIHDPDYVKILLKR	CYP4Z2P	91	Q8N1L4
RPHCKDFLEKIAKLY	CTDP1	226	Q9Y5B0
FPCQDKKYRHRSLLQ	C8A	51	P07357
TKLVKNCFLPLREYF	DNMT3L	361	Q9UJW3
ALLVPDKCKFLHQER	APP	126	P05067
FLYLLHCLLNKKVRE	ADGRE5	781	P48960
FYEILCSLINPKRKD	ADGRV1	5691	Q8WXG9
KKYIVPHLARACVNF	BTBD3	201	Q9Y2F9
IQFKTPIYDLHCNKR	BCAS3	181	Q9H6U6
RCLPFKHKLEIYISE	CIAO2A	106	Q9H5X1
PDRIDLIHKNYRKLC	AP3B1	216	O00203
PERIDLIHKNYRKLC	AP3B2	211	Q13367
LRPHQKEGIIFLYEC	RAD54B	296	Q9Y620
LELKCKIRNHGEYDL	PDZRN4	631	Q6ZMN7
PKCIRAKIQDYHILT	JAK2	211	O60674
KRLLERYIPKHQKCL	ANKRD31	601	Q8N7Z5
LCAKHGIEYQEKPLL	FADS2	406	O95864
PRVLEKHFGYKLCIF	IL18R1	401	Q13478
CYLPEELAALQKLEH	FLII	46	Q13045
DDPRLGIQKIFLCKY	LLGL2	501	Q6P1M3
NKIYCVRDYHKVLAP	LIMD1	581	Q9UGP4
ALDRLHYEKDPCVKY	NFRKB	626	Q6P4R8
DLELFKKLPFDYIIH	GREB1	1401	Q4ZG55
AYRKLAVLLHPDKCV	DNAJC27	236	Q9NZQ0
PIHRQNYKLDCLITD	EPHX4	136	Q8IUS5
NKDLHIPELRDCRYL	GLB1L3	491	Q8NCI6
IDNPQDLKVHLYKCA	PLXNA2	791	O75051
INHYFCDLVPLLKLA	OR4X2	166	Q8NGF9
QHKDCVVPYLLRLLK	PI4KA	91	P42356
LPCLDTYHKVDLRLQ	NPHS2	156	Q9NP85
IDCYEKYKVLPRIHD	LRPPRC	846	P42704
EHYVNCLDLVNKRLP	POLG2	191	Q9UHN1
CLRTPHLEKRYKIQF	ELP1	476	O95163
DLHYFPTEILCLKNL	LRRC63	356	Q05C16
HCPEKISENKFLKYL	MTPAP	81	Q9NVV4
LDFCILLLYAQPKAK	MGAT4D	236	A6NG13
DFLLIHYDKGPCRNK	RNF144A	221	P50876
KLNHFFYDVKPLLEL	OR12D3	171	Q9UGF7
RIYHFFCDVKPLLKL	OR12D1	171	P0DN82
YIPKLLQLFHTCENL	PPP4R3C	171	Q6ZMV5
LELEKEFHFNKYLCR	HOXB2	156	P14652
YKLGDDLLQCHPAVK	PROC	166	P04070
LLAHQKPFIRKSYKC	MUC7	51	Q8TAX7
PLHVCEQRDVKGLYK	PAPSS1	161	O43252
FHALKIKKNYLPLCA	ETFDH	16	Q16134
KSAVQLFEKHPCLYI	CEPT1	306	Q9Y6K0
FLRLCKKNHDEIYPI	CASP5	171	P51878
LPKREHLQYLYEKLA	DCLRE1C	661	Q96SD1
LRKCSYYIEVLPKHL	FNDC11	71	Q9BVV2
HLKTYPNCFVAKELI	DEPTOR	56	Q8TB45
LLPLVHQCYLKKSKR	GLRX2	146	Q9NS18
LDCKHRDLVDYLDPL	ANKS6	266	Q68DC2
LCKQHKLYITPALND	DNAAF1	96	Q8NEP3
AYRKLALKFHPDKNC	DNAJC18	101	Q9H819
HKVDFILQREPYCRD	KHNYN	651	O15037
ENIHENCLKAIRPYL	DNAH9	3231	Q9NYC9
KECEYNPKFRLILHT	DNAH9	3541	Q9NYC9
EEKQLELCQRLYKLH	FRY	2821	Q5TBA9
QNFCKRPDIIRKHLY	GTDC1	416	Q4AE62
KYEQELFKLALPCLS	RYR2	2656	Q92736
YKDCKPLLLDNIHFS	IL1R1	161	P14778
VKDVLFIRPRKYIHC	JADE3	101	Q92613
PRQLKDKADFCIIHY	MYH10	566	P35580
KSRKNLLHCYEVIPE	PRIMPOL	91	Q96LW4
HCIKGYLLRSEPKRD	RIN3	941	Q8TB24
KLKQAFYIPRNLEHL	OMD	291	Q99983
LELEKEFHFNKYLCR	HOXA2	156	O43364
DRYVAICKPLHYKRI	OR52I2	151	Q8NH67
KEHPRDLKFSIDYIL	FOXL3	186	A0A1W2PRP0
YFLIFDLLVKLCNPK	GLMN	86	Q92990
LLYPLCHKRFQKAFL	HRH4	356	Q9H3N8
LQRLYRLHKDCPKVQ	SERAC1	301	Q96JX3
KDLFHCKPKEILYVC	SLFN14	611	P0C7P3
HRLYQLSKAGKLCVP	AHCYL2	341	Q96HN2
HQLCLKDQPKSRYFL	RNF183	96	Q96D59
IDAKCHKDLPRDIQF	ALOX5	156	P09917
LKKFYEVNHCLPEKI	PIWIL2	796	Q8TC59
LYLLKDFNPLDVHKI	TDRD10	51	Q5VZ19
EEYEPHLFTNKLKCE	SKIDA1	696	Q1XH10
PLQVALECLYHREKR	TEKT5	186	Q96M29
IPDNELHLIKLCAFY	WDR17	1046	Q8IZU2
EILFHYADRALKKCP	VPS8	551	Q8N3P4
IYHRCEFKIPLAIKK	PHAF1	321	Q9BSU1
IPADLRLCHNVGYKK	SFRP1	61	Q8N474
LLLALEPHKEQYKEF	RIPOR2	611	Q9Y4F9
IRLCQKFGEYHKDDP	SEC23A	551	Q15436
REHVVKIPLKRCQFY	SEMA5A	476	Q13591
KQHDCDYKILPALGV	TET1	136	Q8NFU7
HCVLPKDQSILLKYQ	CCDC15	431	Q0P6D6
KFLYCEPHKRIKEVL	C11orf97	51	A0A1B0GVM6
VHLEVLNARQPYKCK	ZNF561	186	Q8N587
FLEEIPDYKLNHALC	TLR3	851	O15455
TEFYKHCGPRLKILQ	UNC80	2501	Q8N2C7
ELRCKVFPIKHYQDK	TRIB1	116	Q96RU8
RKPVDEYKDCHLAQV	TF	251	P02787
KRPENYFKHIKEACI	RINT1	721	Q6NUQ1
DHPIDLLLRDFKKNY	SPARCL1	571	Q14515
DYKLKNIFRLHELPV	SPAG16	341	Q8N0X2
HNCEPYKRLFKAKNL	ZPBP	251	Q9BS86
RQRFLHCTEKDLIPY	SNRNP200	1586	O75643
EKPYRYIECDKALNH	ZNF415	261	Q09FC8
YLKFIELPLTQRKFC	ZCCHC4	111	Q9H5U6
AEFKKEEPRALYIHC	ZMYM1	731	Q5SVZ6
ALLLPHCQKLFVYDL	UBAC2	31	Q8NBM4
YPEINRFLKLLHQCK	TYW1	491	Q9NV66
QSNHLPKYERVKELC	SULF1	431	Q8IWU6
HKRCPDYIIQKLNIV	PTPRC	786	P08575
FQDIPKRCLKAREHF	TSN	51	Q15631
KPKTFQAYLDDCHRR	YPEL3	6	P61236
EDKLRHFRECFYIPK	KYNU	36	Q16719
ALRHLYVLVNLCEKP	LGMN	401	Q99538